Advertisement
Singapore markets closed
  • Straits Times Index

    3,280.10
    -7.65 (-0.23%)
     
  • Nikkei

    37,934.76
    +306.28 (+0.81%)
     
  • Hang Seng

    17,651.15
    +366.61 (+2.12%)
     
  • FTSE 100

    8,138.85
    +59.99 (+0.74%)
     
  • Bitcoin USD

    64,452.34
    +976.59 (+1.54%)
     
  • CMC Crypto 200

    1,344.84
    -51.69 (-3.70%)
     
  • S&P 500

    5,101.45
    +53.03 (+1.05%)
     
  • Dow

    38,269.98
    +184.18 (+0.48%)
     
  • Nasdaq

    15,909.80
    +298.04 (+1.91%)
     
  • Gold

    2,351.50
    +9.00 (+0.38%)
     
  • Crude Oil

    83.71
    +0.14 (+0.17%)
     
  • 10-Yr Bond

    4.6490
    -0.0570 (-1.21%)
     
  • FTSE Bursa Malaysia

    1,575.16
    +5.91 (+0.38%)
     
  • Jakarta Composite Index

    7,036.08
    -119.22 (-1.67%)
     
  • PSE Index

    6,628.75
    +53.87 (+0.82%)
     

Is This the Telltale Sign to Sell Novavax Stock?

Is This the Telltale Sign to Sell Novavax Stock?

Unfortunately, Novavax (NASDAQ: NVAX) hasn't had great timing. The company was late to the party in winning authorizations for its COVID-19 vaccine, Nuvaxovid. If you only looked at Novavax's press releases, you wouldn't know about some recent bad news for the company.